Hubei five Swiss biotechnology co., Ltd.---Hubei and casings in China, one of the industry's largest supplier of direct production of sodium heparin. since 1987 founded yilai, abide by and practice internationalization of market strategy, and height reliable of mass control system, and professional of technology team and people and natural harmonious symbiosis of enterprise concept, existing registered capital 10 million Yuan, years sales 200 million Yuan, to Koike headquarters for Center, in Beijing, and Wuhan, and Zhengzhou, and Changchun, and Hefei, and Qingdao, 12 a provinces established has branch institutions, formed has strong of resources control ability.

five Swiss company led production casing, and liver pigment sodium, and low molecular liver pigment sodium, and bilirubin, and Cholic acid sodium, and carboxy methyl sodium starch, green food and the bio medicine intermediate products, casing, and liver pigment sodium, and sulfuric acid cartilage pigment supporting machinery device, and chemical dedicated device, has by EU certification of casing workshop, and standardization of device manufacturing workshop and GMP standard construction of biochemical workshop. the company to outstanding quality and service, successfully occupied the country, as well as the European Union, the United States, and Japan, Southeast Asia and other international markets. with many internationally renowned companies such as United States Pfizer, and France Sanofi, and Germany Dohr, and Netherlands Teeuwissen, and Spain Bioiberica company, has established a good stable cooperation and certification as its raw material suppliers in China.

five insight was one of the first batch of 150 innovative pilot enterprises in Hubei Province, high-tech enterprises, agricultural industrialization leading enterprises. has passed ISO9001 and ISO14001 certification, and the EU health register, obtained 16 patents, including 2 invention patents. the company and the National Engineering Research Center for nanomedicine, Huazhong University jointly set up a biochemical drugs research center, the two sides established a cooperative relationship of long-term, sustainable.

we will grasp the market opportunity, forge ahead, relying on resource control has developed, technology research and development and marketing network, to create a model of innovation, environmental protection, sustainable development, international major authentication vendors, heparin market standard enterprise in China, fighting for 3-5 years to reach $ 1 billion industry, 5-7 gem.

we will create be led by food processing, bio-pharmaceuticals, machinery and equipment, industrial park covers an area of more than 80,000 square meters of five Swiss, while consolidating the quality of enterprise resources, and look forward to working with strong domestic and international strategic investor alliances.